Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verisk Analytics
VRSK
|
+$438M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$309M |
| 3 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$274M |
| 4 |
PepsiCo
PEP
|
+$229M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
Vanguard Total Stock Market ETF
VTI
|
+$752M |
| 3 |
Vanguard Dividend Appreciation ETF
VIG
|
+$448M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$351M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.02% |
| 2 | Healthcare | 5.4% |
| 3 | Consumer Discretionary | 4.87% |
| 4 | Financials | 4.64% |
| 5 | Industrials | 3.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKRO
1426
DELISTED
Akero Therapeutics
AKRO
| $4.88M | ﹤0.01% |
96,490
+23,955
| +33% | +$1.12M |
|
1427
Vaxcyte
PCVX
$7.65B
| $4.87M | ﹤0.01% |
95,439
+16,816
| +21% | +$830K |
|
1428
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.35B
| $4.85M | ﹤0.01% |
102,746
+9,946
| +11% | +$473K |
|
1429
CALL
Capital One
COF
$129B
| $4.85M | ﹤0.01% |
50,000
-741,600
| -94% | -$79.3M |
|
1430
Immunovant
IMVT
$7.79B
| $4.85M | ﹤0.01% |
126,316
+38,179
| +43% | +$863K |
|
1431
PUT
Yum China
YUMC
$15.9B
| $4.85M | ﹤0.01% |
87,000
+30,000
| +53% | +$1.68M |
|
1432
Murphy Oil
MUR
$5.5B
| $4.85M | ﹤0.01% |
106,889
-42,773
| -29% | -$1.86M |
|
1433
Lyft
LYFT
$5.84B
| $4.84M | ﹤0.01% |
459,452
-53,973
| -11% | -$601K |
|
1434
PUT
Ascendis Pharma A/S
ASND
$16.6B
| $4.83M | ﹤0.01% |
51,600
+26,600
| +106% | +$2.49M |
|
1435
CALL
IMAX
IMAX
$2.59B
| $4.83M | ﹤0.01% |
250,000
| – | – |
|
1436
Trip.com Group
TCOM
$29.2B
| $4.81M | ﹤0.01% |
137,440
-22,224
| -14% | -$836K |
|
1437
CALL
TotalEnergies
TTE
$192B
| $4.8M | ﹤0.01% |
73,000
+53,000
| +265% | +$3.28M |
|
1438
Teleflex
TFX
$5.9B
| $4.8M | ﹤0.01% |
24,429
-3,184
| -12% | -$722K |
|
1439
Vanguard Total World Stock ETF
VT
$75.6B
| $4.79M | ﹤0.01% |
51,391
+23,610
| +85% | +$2.29M |
|
|
LBC
1440
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $4.78M | ﹤0.01% |
568,954
-20,364
| -3% | -$189K |
|
1441
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.6B
| $4.78M | ﹤0.01% |
121,782
+1,940
| +2% | +$76.9K |
|
|
PYCR
1442
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $4.76M | ﹤0.01% |
208,690
-2,038
| -1% | -$48.6K |
|
1443
Western Alliance Bancorporation
WAL
$8.9B
| $4.76M | ﹤0.01% |
103,471
-27,318
| -21% | -$1.29M |
|
1444
Beam Therapeutics
BEAM
$2.66B
| $4.75M | ﹤0.01% |
197,597
+34,943
| +21% | +$937K |
|
1445
Bio-Rad Laboratories Class A
BIO
$8.8B
| $4.71M | ﹤0.01% |
13,137
-1,799
| -12% | -$694K |
|
|
MASI
1446
DELISTED
Masimo
MASI
| $4.7M | ﹤0.01% |
53,583
-11,324
| -17% | -$1.32M |
|
1447
iShares Silver Trust
SLV
$27.5B
| $4.69M | ﹤0.01% |
230,511
-145,060
| -39% | -$3.13M |
|
1448
Apollo Global Management Series A
APO.PRA
$1.75B
| $4.68M | ﹤0.01% |
+85,000
| New | +$4.58M |
|
|
RBCP
1449
DELISTED
RBC Bearings Incorporated 5.00% Series A Mandatory Convertible Preferred Stock
RBCP
| $4.66M | ﹤0.01% |
42,317
| – | – |
|
|
FSR
1450
PUT
DELISTED
Fisker Inc.
FSR
| $4.65M | ﹤0.01% |
+725,000
| New | +$4.41M |
|
Similar funds
Citigroup's Q3 2023 Portfolio in Review
As of Q3 2023, Citigroup held 5,915 positions worth $134B, down 12% from $153B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citigroup withdrew a net $13.8B in Q3 2023, closing 265 positions and reducing 3,110 holdings. Its most notable exit was Magellan Midstream Partners, L.P., an estimated $121M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Citigroup opened a new position in Opera Ltd worth $31.8M.
- Citigroup's largest Q3 2023 buy was Opera Ltd: 2,825,474 shares worth $31.8M.
- Citigroup added most to Verisk Analytics in Q3 2023, an estimated $438M increase.
- Citigroup's biggest Q3 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citigroup fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $121M.
- Citigroup's ten largest holdings make up 30% of its $134B portfolio in Q3 2023.
- Citigroup opened 337 new positions and closed 265 in Q3 2023.
- Citigroup's portfolio value fell 12% quarter-over-quarter to $134B.
Based on Citigroup's 13F filing for Q3 2023, filed 9 Nov 2023.